Short-term perioperative outcomes among patients with concurrent asymptomatic and mild SARS-CoV-2 infection: A retrospective, multicenter study무증상 및 경증 SARS-CoV-2 감염 환자의 단기 수술 전후 결과: 후향적, 다기관 연구Multicenter Study Published on 2022-06-012022-09-11 Journal: Surgery [Category] COVID19(2023년), SARS, 치료기술, [키워드] 30-Day mortality Admission Asymptomatic categorization center Chinese Cohort Control COVID COVID-19 COVID-19 infection COVID-19 infections COVID-19 symptom criteria determine diagnosed disease control indications Infection initial management Mild mild COVID-19 symptoms morbidity morbidity and mortality Mortality mortality rates multicenter New obtundation operative risk outcome overall mortality Patient patients patients with asymptomatic patients with SARS-CoV-2 performed postoperative prevention Previous studies previous study Primary outcome pulmonary complication pulmonary complications retrospective Retrospective study risk SARS-CoV-2 secondary outcome Secondary outcomes severity surgery surgical was used weighed [DOI] 10.1016/j.surg.2021.12.024 PMC 바로가기 [Article Type] Multicenter Study
Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from IndiaRandomized Controlled Trial Published on 2022-06-012022-10-04 Journal: BMJ Open [Category] 임상, [키워드] 1:1 95% CI addition adverse event age ARMS assigned clinical pharmacology control arm COVID-19 COVID-19 infection Definitive determine female healthcare healthcare worker heterogeneity hospital Hydroxychloroquine hydroxychloroquine group India intervention arm laboratory-confirmed multicentre no significant difference Open-label parallel-group participant Personal protective equipment precluded primary analysis proportion public health randomisation randomised randomised controlled trial Randomised trial reduce screened Secondary outcomes Serious Adverse Event the primary endpoint Treatment Trial [DOI] 10.1136/bmjopen-2021-059540 PMC 바로가기 [Article Type] Randomized Controlled Trial
Mesenchymal stem/stromal cell-based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19COVID-19에 대한 중간엽 줄기/기질 세포 기반 치료법: 살아있는 체계적인 검토 및 메타 분석의 첫 번째 반복: MSC 및 COVID-19Meta-Analysis Published on 2022-06-012022-09-11 Journal: Cytotherapy [Category] COVID19(2023년), SARS, 치료기술, [키워드] 95% CI 95% confidence interval acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adherence adverse effects Analysis appear case sery Cell Cell-based therapy Clinical outcome Control coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 criteria Critical determine Efficacy Endpoint estimate Exosomes Extracellular Extracellular vesicles Follow-up Future heterogeneity immunomodulatory interleukin-6 ISCT iteration Mesenchymal stem cells Mesenchymal stromal cells Meta-analysis Microvesicles moderate Mortality MSC MSCs nine not performed Other outcome Other outcomes pandemic patients patients with COVID-19 performed Pneumonia potential risk primary analysis random-effect random-effects repeated reported respiratory distress Respiratory distress syndrome risk risk of bia risk of death risk ratio RoB SARS-CoV-2 Secondary outcomes secreted Sepsis severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 standardized mean difference Statistical power stromal cells Study design systematic review therapy for COVID-19 tissue repair treat [DOI] 10.1016/j.jcyt.2021.12.001 PMC 바로가기 [Article Type] Meta-Analysis
Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19중증 COVID-19 환자 치료에서 토실리주맙과 메틸프레드니솔론의 효능 및 안전성 비교Article Published on 2022-06-012022-09-11 Journal: International immunopharmacology [Category] COVID19(2023년), SARS, 바이오마커, 진단, 치료기술, 치료법, [키워드] 28-day mortality 95% CI adverse event adverse events alternative caused clinical clinical response comparable COVID Cox regression analysis CRP Dexamethasone dose doses duration of hospitalization Efficacy and safety faster group groups hospitalized patient hospitalized patients ICU admission improvement intravenous methylprednisolone Methylprednisolone not significantly different occurred Other outcome oxygen oxygen saturation Patient Primary outcome problem prospective cohort study secondary Secondary outcomes severe COVID-19 Sleep disturbance Sleep disturbances statistically significant Tocilizumab Treatment were recorded [DOI] 10.1016/j.intimp.2022.108689 PMC 바로가기 [Article Type] Article
Implementation of the ERAS (Enhanced Recovery After Surgery) protocol for hysterectomy in the Piedmont Region with an audit&feedback; approach: Study protocol for a stepped wedge cluster randomized controlled trial. A study of the EASY-NET project감사 및 피드백과 함께 Piedmont 지역의 자궁절제술을 위한 ERAS(수술 후 회복 강화) 프로토콜 구현 접근 방식: 계단형 쐐기형 클러스터 무작위 대조 시험을 위한 연구 프로토콜. EASY-NET 프로젝트 연구Article Published on 2022-05-272022-09-11 Journal: PLoS ONE [Category] 임상, [키워드] activate adopted all the patients approach approved assigned changes in Clinical outcome Clinical studies clinical study clinically Cluster Committee Compliance complications Controlled trial COVID-19 pandemic detect effect size endpoints enhanced ERAS ethical committee expected four groups healthcare hospital Hospital stay Hospitalized Hysterectomy implementation Intervention involved LOS management multicenter outcome Patient peer-reviewed Piedmont positive Primary outcome promote protocol provide Randomized controlled trial randomized trial Randomly reduce reduction Region Result Sample size Satisfaction secondary Secondary outcomes selected Statistical power stratified Stress stress response Study protocol surgery surgical Surgical stress the patient Volume women [DOI] 10.1371/journal.pone.0268655 PMC 바로가기 [Article Type] Article
Effects of different doses of methylprednisolone on clinical outcomes in patients with severe community-acquired pneumonia: a study protocol for a randomized controlled trial중증 지역사회획득 폐렴 환자의 임상 결과에 대한 다양한 용량의 메틸프레드니솔론 효과: 무작위 대조 시험을 위한 연구 프로토콜Article Published on 2022-05-212022-09-11 Journal: Trials [Category] COVID19(2023년), SARS, 임상, [키워드] 28-day mortality Chinese clinical Clinical efficacy Clinical outcome clinician community-acquired pneumonia complications Consensus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 treatment determine diagnosed different dose different doses dose dose-dependent double-blind Effect Efficacy Efficacy and safety Endotracheal intubation evaluate Final four group Frequency gastrointestinal hemorrhage glucocorticoid help Hospital stay hyperglycemia ICU interleukin interleukin-6 mechanical ventilation duration Methylprednisolone normal saline Nosocomial infections optimal dose PaO parallel group Patient Placebo placebo-controlled trial Primary outcome protocol randomization Randomized Randomized controlled trial registry SCAP secondary outcome Secondary outcomes serum CRP Severe community-acquired pneumonia. Study protocol temperature treat Treatment Vasopressor vasopressors ventilator-free day Volume [DOI] 10.1186/s13063-022-06404-8 PMC 바로가기 [Article Type] Article
SARS-CoV-2 humoral immune response in patients with cardiovascular risk factors: the COmmunity Cohort Study protocol심혈관 위험 인자가 있는 환자의 SARS-CoV-2 체액성 면역 반응: 커뮤니티 코호트 연구 프로토콜Article Published on 2022-05-192022-09-11 Journal: BMJ Open [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Adult patients anti-SARS-CoV-2 vaccine anti-SARS-CoV-2 vaccines antibody approved baseline blood sample cardiovascular cardiovascular risk cardiovascular risk factors clinics Cohort collected Community conducted Contact contact with COVID-19 death defined detectable determine disseminate eligible Epidemiology Ethics ethics committee exposure exposure to face-to-face contact follow-up time Health care humoral immune response IgG antibody immunology Inclusion International Local Memorandum mixed-effects model morbidity National neutralising Neutralising Antibodies neutralising antibody outcome pandemic participant Patient peer-reviewed Prevent primary care Primary outcome Primary outcomes prospective cohort study protocol questionnaire recruitment Registered Research Sample size SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens secondary Secondary outcomes Seroconversion service South strength Study protocol vaccination website [DOI] 10.1136/bmjopen-2022-061345 PMC 바로가기 [Article Type] Article
Foot–ankle therapeutic exercise program can improve gait speed in people with diabetic neuropathy: a randomized controlled trial Research Published on 2022-05-092022-10-05 Journal: Scientific Reports [Category] 임상, [키워드] complementary Control control group controls determine Diabetic functional gait speed group IMPROVE intention-to-treat analysis intervention group Musculoskeletal Participants physical activity Primary outcome Quality of life Randomized controlled trial remained Secondary outcomes significantly single-blind therapeutic Treatment usual care Volunteer [DOI] 10.1038/s41598-022-11745-0 [Article Type] Research
Adequacy of Serial Self-performed SARS-CoV-2 Rapid Antigen Detection Testing for Longitudinal Mass Screening in the Workplace직장에서 종방향 질량 스크리닝을 위한 연속 자가 수행 SARS-CoV-2 신속 항원 검출 테스트의 적절성Article Published on 2022-05-022022-09-11 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 치료기술, [키워드] Accuracy Adequacy age analyses analyzed antigen detection Asymptomatic Canada community transmission Contact contact with criteria Critical cross-sectional cross-sectional study detection feasibility Frequency improvement Improvements infected with SARS-CoV-2 Interpretation invalid longitudinal mass Measures median men Montreal Montreal, Canada not differ outcome participant Participants performed positive proportion proportions provided Public quarantine Rapid repeated required SARS-CoV-2 SARS-COV-2 infection Screening secondary Secondary outcomes significantly test validity Testing Validity was performed Workplace [DOI] 10.1001/jamanetworkopen.2022.10559 PMC 바로가기 [Article Type] Article
The impact of neutralizing monoclonal antibodies on the outcomes of COVID-19 outpatients: A systematic review and meta-analysis of randomized controlled trials중화 단일클론항체가 COVID-19 외래 환자의 결과에 미치는 영향: 무작위 대조 시험의 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-05-012022-09-11 Journal: Journal of medical virology [Category] 임상, 진단, [키워드] 95% confidence interval addition adverse event adverse events AEs article clinical Clinical efficacy Cochrane Library control group controlled trials coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 outpatient COVID-19 outpatients database emergency department Health Organization help higher risk Hospitalization ICTRP inception lower risk mAbs Meta-analysis monoclonal mortality rate Neutralizing neutralizing monoclonal antibodies neutralizing monoclonal antibody Odds ratio Odds ratios outcome Outpatient outpatients Patient patients Placebo Primary outcome Randomized controlled trial RCTs reduce registry risk risk of death Safe Safety searched secondary outcome Secondary outcomes serious AE serious AEs significantly lower systematic review the patient Treatment was used Web of Science World Health Organization [DOI] 10.1002/jmv.27623 PMC 바로가기 [Article Type] Meta-Analysis